Literature DB >> 11826248

Cochleovestibular impairment in pediatric Cogan's syndrome.

Issa C Ndiaye1, Simon J Rassi, Sylvette R Wiener-Vacher.   

Abstract

Cogan's syndrome is a rare, chronic inflammatory disorder that typically targets the eyes and vestibuloauditory apparatus, but it may also involve other organs. Three pediatric cases of Cogan's syndrome (ages 5, 13, and 18 years) are reported with long-term follow-up and complete and regular cochleovestibular functional evaluation and ophthalmologic and neurologic examinations. One case was a typical form (characterized by an interstitial keratitis and cochleovestibular impairment), whereas the other 2 cases were atypical forms with uveitis and polyarthritis. In all 3 cases, the first clinical sign was nonspecific eye redness misdiagnosed as a banal conjunctivitis, initially or secondarily associated with bilateral endocochlear sensorineural hearing loss and complete bilateral peripheral vestibular deficit. During the acute phase, early steroid treatment (prednisone, 1 mg/kg/day) was effective in treating the ocular lesions (3 of 3 cases) and improving hearing (2 of 3 cases) but less effective for the vestibular loss (2 of 3 cases). Adverse effects and dependence on the steroid occurred in 2 cases, and immunosuppressive drugs were necessary to avoid recurrences in 1 case. Over the long-term, the disease was controlled in 2 cases but continued to progress in the other. Cogan's syndrome in childhood should be suspected in cases of conjunctivitis associated with inner-ear symptoms; a prompt steroid treatment can avoid progressive impairment of multiple sensorineural functions (vision, balance, hearing). Long-term management involves limiting disease recurrences by adaptive therapies, screening for complications (aortitis in particular), and planning rehabilitation for the sensorial deficits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11826248     DOI: 10.1542/peds.109.2.e38

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Low-dose oral methotrexate for the management of childhood Cogan's syndrome: a case report.

Authors:  Yuzaburo Inoue; Takuya Tomemori; Shuichi Suzuki; Takayasu Arima; Minako Tomiita; Naoki Shimojo; Yoichi Kohno
Journal:  Clin Rheumatol       Date:  2007-07-05       Impact factor: 2.980

Review 2.  Epidemiology of Vestibular Impairments in a Pediatric Population.

Authors:  Sylvette R Wiener-Vacher; Juliette Quarez; Audrey Le Priol
Journal:  Semin Hear       Date:  2018-07-20

Review 3.  COGAN'S SYNDROME.

Authors:  Daniela Adriana Iliescu; Cristina Mihaela Timaru; Mehdi Batras; Algerino De Simone; Cornel Stefan
Journal:  Rom J Ophthalmol       Date:  2015 Jan-Mar

Review 4.  Syndromes of hearing loss associated with visual loss.

Authors:  Kamal Ahmed Abou-Elhamd; Hesham Mohamed ElToukhy; Fahad Abdullah Al-Wadaani
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-30       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.